Lancet Diabetes Endocrinol 4:52536
[18] showed that intravenous infusion of GLP-1 for 48 hours in animal models with induced dilated cardiomyopathy significantly improved LV contractility, stroke volume, and cardiac output
That competition will be great for the stakeholders paying for healthcare (patients, employers, and the government)
In some cases, arbitration will also be involved
Nature paper (8 Apr 2026) by the 23andMe Research Team reports the first large-scale, genome-wide association study (GWAS) of GLP-1 medication treatment response specifically for semaglutide and tirzepatide
Potential Role of GLP-1 in Psychiatry (And Inflammation) When our patients are in a state of severe depression or chronic psychosis, their microglia are frequently locked into a pro-inflammatory, neurotoxic M1 phenotype